Ruder Finn has appointed Kelley Yoder as Global Head of Health and Life Sciences, marking a significant strategic investment focused on innovation and growth within the healthcare sector.

The drug abuse testing market is on track to grow significantly, projected to hit $8.9 billion by 2033, driven by rising drug abuse rates and stringent regulations.

The prescription drugs market is experiencing significant growth, projected to reach $2.15 trillion by 2032, driven by innovative therapies and patient-focused policies.

Astrana Health, Inc. reports impressive growth in its Q1 2025 results, including a 53% increase in total revenue, showcasing its success in providing high-quality healthcare services.

With the Trump tariffs on imported goods, the health and wellness sector faces potential disruption. However, industry experts suggest minimal impact overall.

The latest Hospital ISM® Report reveals continued economic expansion in the hospital sector for the 18th month, driven by various health concerns and ongoing supply chain dynamics.

FleishmanHillard announces the appointment of Mary Kosinski as global managing director of Health and Life Sciences, enhancing leadership.